Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
52.74 USD | +54.21% | +42.31% | +29.39% |
03/06 | Structure Therapeutics Plans Offering of American Depositary Shares | MT |
03/06 | Top Midday Gainers | MT |
Business Summary
Number of employees: 93
Managers
Managers | Title | Age | Since |
---|---|---|---|
Raymond Stevens
FOU | Founder | 60 | 01/19/01 |
Jun Yoon
DFI | Director of Finance/CFO | 46 | 01/19/01 |
Ying Li Ma
CTO | Chief Tech/Sci/R&D Officer | 50 | 01/22/01 |
Xi Chen Lin
CTO | Chief Tech/Sci/R&D Officer | 50 | 01/19/01 |
Mark Bach
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/21/01 |
Lani Ibarra
CTO | Chief Tech/Sci/R&D Officer | - | - |
Tony Peng
LAW | General Counsel | - | - |
Karen S. Wright
AUD | Comptroller/Controller/Auditor | 69 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Sharon Tetlow
BRD | Director/Board Member | 64 | 29/22/29 |
Ted Love
BRD | Director/Board Member | 65 | 03/23/03 |
Eric Dobmeier
BRD | Director/Board Member | 55 | 01/22/01 |
Daniel Welch
CHM | Chairman | 66 | 19/22/19 |
Ramy Farid
BRD | Director/Board Member | 59 | 01/19/01 |
Raymond Stevens
FOU | Founder | 60 | 01/19/01 |
Jun Yoon
DFI | Director of Finance/CFO | 46 | 01/19/01 |
Director/Board Member | 64 | 01/22/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 2,161 | 0 | 0 | 76.06 % |
Stock B | 0 | 32,857 | 0 | 0 | |
Stock C | 1 | 139,794,124 | 106,321,015 ( 76.06 %) | 0 | |
Stock D | 0 | 12,800 | 0 | 0 | |
Stock E | 0 | 19,200 | 0 | 0 |
Company contact information
Structure Therapeutics, Inc.
601 Gateway Boulevard Suite 900
94080, South San Francisco
+
http://www.structuretx.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.39% | 2.46B | |
+15.55% | 121B | |
+12.66% | 107B | |
-2.53% | 24.82B | |
+1.19% | 22.48B | |
-9.51% | 18.32B | |
-42.28% | 16.33B | |
-18.92% | 15.31B | |
+6.19% | 14.08B | |
+28.83% | 11.74B |
- Stock Market
- Equities
- GPCR Stock
- Company Structure Therapeutics Inc.